News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Daly James M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $43.711, valued at
$437.1k
Sold 10,000 shares
@ $43.741, valued at
$437.4k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
4
| Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 01/05/2023 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 60,414 shares
@ $0 |
|
| 09/02/2022 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 35,082 shares
@ $0 |
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2021 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 6,500 options to buy
@ $3.05, valued at
$19.8k
|
|
| 07/06/2021 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 809 restricted stock units
@ $0 |
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4
| Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,363 shares
@ $40.413, valued at
$418.8k
|
|
| 08/13/2020 |
4
| Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 34,337 shares
@ $29.12, valued at
$999.9k
|
|
| 06/25/2020 |
4
| Daly James M (Director) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 5,579 options to buy
@ $52.73, valued at
$294.2k
Granted 3,059 restricted stock units
@ $0 |
|
| 06/18/2020 |
4
| Daly James M (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 6,000 options to buy
@ $111.06, valued at
$666.4k
|
|
| 06/16/2020 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 6,500 options to buy
@ $8.42, valued at
$54.7k
|
|
| 05/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2020 |
4
| Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,829 shares
@ $0 |
|
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2019 |
4
| Daly James M (Director) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $100.45, valued at
$2M
|
|
| 07/01/2019 |
3
| Daly James M (Director) has filed a Form 3 on MADRIGAL PHARMACEUTICALS, INC. |
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Daly James M (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 21,000 options to buy
@ $3.37, valued at
$70.8k
|
|
| 06/14/2019 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 25,000 options to buy
@ $1.96, valued at
$49k
|
|
| 05/03/2019 |
4
| Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Granted 12,173 shares
@ $0 |
|
| 06/21/2018 |
4
| Daly James M (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 21,000 options to buy
@ $4.82, valued at
$101.2k
|
|
| 06/18/2018 |
4
| Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 10,000 options to buy
@ $9.8, valued at
$98k
|
|
| 06/08/2018 |
4
| Daly James M (Director) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $17.52, valued at
$262.8k
|
|
| 05/02/2018 |
4
| Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Granted 10,363 shares
@ $0 |
|
|
|
|